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EFFECT OF BACLOFEN ON LIQUID AND 
SOLID GASTRIC EMPTYING IN RATS 
Edgard Ferro COLLARES1, 2 and Adriana Mendes VINAGRE2
ABSTRACT – Context - Gamma-aminobutyric acid (GABA) is a potent inhibitory neurotransmitter. There is evidence that GABAB 
receptors located in the dorsal complex and in afferent fibers of the vagus nerve participate in the control of gastrointestinal motility. 
Objectives - To assess the intracerebroventricularly (ICV) and intravenously (IV) effect of baclofen, a GABAB receptor agonist, on 
liquid and solid gastric emptying in rats. Methods - Adult male Wistar rats weighing 250-300 g (n = 6-8 animals) were used. Gastric 
emptying of liquid test meals labeled with phenol red was evaluated by the determination of percent gastric retention (%GR) 10 and 
15 min after orogastric administration of saline and 10% glucose meals, respectively. Baclofen was injected ICV (1 and 2 mg/animal) 
through a tube implanted into the lateral ventricle of the brain and was injected IV (1 and 2 mg/kg) into a tail vein. The gastric 
emptying of liquid was determined 10 or 30 min after ICV and IV baclofen administration, respectively. The gastric emptying of 
the solid meal was assessed by the determination of percent gastric retention 2 h after the beginning of the ingestion of the habitual 
ratio by the animal, consumed over a period of 30 min. Baclofen was administered ICV (1 and 2 mg/animal) or IV (1 and 2 mg/kg) 
immediately after the end of the ingestion of the solid meal. The control groups received vehicle (sterile saline solution) ICV or IV. 
Results - The group of animals receiving baclofen ICV (2 mg/animal) presented a significantly lower (P<0.05, Tukey test) %GR (mean 
± SEM) of the saline (18.1 ± 2.5%) compared to control (33.2 ± 2.2%). In the group receiving the drug IV, the gastric retention of the 
same test meal did not differ from control. ICV and IV administration of baclofen had no effect on the gastric emptying of the 10% 
glucose solution compared to control. ICV administration of 1 or 2 mg baclofen/animal significantly increased the gastric retention 
of the solid test meal (57.9 ± 6.5% and 66.6 ± 6.3%, respectively) compared to control (35.1 ± 4.4%). The same phenomenon was 
observed only with the IV dose of 2 mg/kg (71.9 ± 2.6%) compared to control (52.7 ± 2.8%). Conclusions - Baclofen administered: 
1. ICV (2 mg/animal), but not IV, increased gastric emptying of a non-caloric isotonic liquid test meal (saline); 2. when administered 
ICV or IV, it had no effect of gastric emptying of a 10% glucose solution; 3) when administered ICV (1 and 2 mg/animal) and IV (2 
mg/kg) it delayed the gastric emptying of the solid meal. 
HEADINGS – Gastric emptying. Baclofen. Rats. 
INTRODUCTION
Gastric emptying (GE) is the transfer of the gastric 
content to the small intestine as the result of stimulating 
and inhibiting mechanisms that control the motor 
activity of the stomach, pylorus and duodenum. Under 
physiological conditions, GE takes place in an adequate 
manner according to the digestion and absorption 
conditions occurring in the small intestine(44). From 
a functional viewpoint, the stomach is divided into a 
proximal or oral region (fundus and approximately 
one-third of the gastric body) and into a distal or 
caudal region (remainder of  the gastric body and 
antrum)(15, 43, 44). 
Gastric tonus reflects variations in the tonic contractions 
of  the proximal stomach, which is responsible for 
the accommodation of the food bolus and, in part, 
for the GE of liquid(15, 43). The tonus of this region is 
the result of the balance of stimulating (increasing) 
activities and of inhibitory (reducing) activities, with 
regulation largely dependent on the participation of 
the vagus nerve. In general, the reduction of gastric 
tonus reduces fluid GE(2), whereas increased tonus by 
reduction of the gastric fundus is accompanied by 
increased liquid GE(10). The distal stomach presents 
peristaltic activity and is largely responsible for solid food 
GE. By processes of 1. propulsion, 2. evacuation and 
retropulsion, 3. increased retropulsion and trituration, 
the solid fragments are reduced to an appropriate 
size for passing through the pylorus together with 
the liquid phase of the meal(15, 43). The pylorus is not 
a high pressure zone but it contracts independently, 
altering the resistance to flow between the stomach 
and duodenum(44).
Gamma-aminobutyric acid (GABA) is the most 
important inhibitory neurotransmitter in the central 
nervous system (CNS), in which the GABAA, GABAB 
and GABAC receptors have been identified
(5, 13, 21, 28)
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The main effects of the activation of GABAB, receptors, with 
membrane G
αi/Gαo proteins acting as the transducer system, 
are an increase in K+ channel conductance and a decrease in 
Ca++ channel conductance(6, 13, 28).
In the postsynaptic location, the activation of  GABAB 
receptors leads to a prolonged increase in the conductance 
of  the K+ channel, which is responsible for the generation 
of  slow GABAergic inhibitory events in the CNS(14, 28). In 
the presynaptic location, these receptors are involved in 
the regulation of  transmitter release since the main effect 
of  baclofen (β-p-chlorophenyl-GABA), a GABAB receptor 
agonist, by reducing the conductance of  Ca++ channels, 
reduces the release of  stimulating and inhibitory synaptic 
transmitters. This action of  baclofen has been observed 
in a variety of  synapses, with reduction, for example, of 
the release of  noradrenaline, dopamine, acetylcholine, 
serotonin, glutamate, and aspartate(14, 27). It has also been 
observed that baclofen, in the presynaptic location, may 
act as an auto-receptor, reducing the release of  GABA and 
thus reducing the postsynaptic inhibition determined by 
the activation of  GABAA receptors
(14, 27, 28). The GABAB 
receptors in the brain are heterodimers of  two subunits, i.e., 
GABAB(1) and GABAB(2). All known competitive agonist and 
antagonist receptors bind only to the GABAB(1) subunit, 
whereas the activation of  protein G is facilitated by the 
GABAB(2) subunit
(14).
The dorsal vagal complex (DVC) is formed by the nucleus 
tractus solitarii (NTS) with neurons that receive information 
from afferent pathways, the area postrema and the dorsal 
vagal nucleus which contain the stimulatory and inhibitory 
motoneurons, whose axons represent the efferent pathways 
of the vagus nerve(45). 
In the rat, GABAB receptors have a presynaptic location 
in the afferent endings of  the vagus nerve which project 
towards the NTS, with evidence existing that this nucleus is 
also located presynaptically(32).
The use of GABA agonists and antagonists for receptors 
located in the DVC neurons has shown that this acid is 
involved in the control of gastrointestinal motility(3, 19, 38, 46). 
In particular, baclofen, through the vagus nerve, blocks the 
inhibitory stimuli on gastric secretion and increases gastric 
tonus and the frequency and amplitude of gastric and duodenal 
contractions(1, 16, 18, 31).
In a study on the effect of baclofen on GE in mice, the 
drug, when administered intraperitoneally (IP) accelerated 
the GE of solids and delayed the GE of liquid, suggesting 
different effects on the proximal (liquid GE) and the distal 
(solid GE) stomach(40). A surprising result was the reduction 
of GE of the liquid meal since, by increasing gastric tonus, 
baclofen would be expected to increase the GE of such a meal.
On the other hand, in our laboratory we observed that 
baclofen administered intracerebroventricularly (ICV) blocked 
the effect of delayed GE of a saline test meal induced by 
pyrazolone derivatives (dipyrone, 4-aminoantipyrine and 
antipyrine), administered intravenously (IV). No change, or 
only a slight but significant increased in GE of this test meal 
was observed in control animals(12, 39, 42). 
In view of these conflicting data, the objective of the 
present study was to assess in rats the effect of  baclofen 
administered ICV and IV on GE of two liquid meals, a 
noncaloric isotonic one (saline solution), and a caloric one 
(10% glucose solution) and of a caloric solid meal (ration 
habitually ingested by the animal). 
METHODS
We used male Wistar rats weighing 250-300 g, adapted to 
laboratory conditions for at least 2 weeks. The experimental 
protocols used in the present study obeyed the recommendations 
of the Brazilian College of Animal Experimentation (COBEA). 
Before the surgical procedure for the implantation of a cannula 
in the lateral brain ventricle, the animal was sedated with an 
IP injection of thiopental, 75 mg/kg. After the procedure or 
entry into the study, the animals were kept in individual cages 
with free access to ration and water. 
At the time of the study, (±)-baclofen (Sigma) was diluted 
in sterile physiological saline used as vehicle and the IV and 
ICV doses were those used in other studies(12, 40). 
The same lot of autoclavable 6003 Nuvilab CR-1 ration 
for rats and mice was used as the solid test meal. The mean 
composition of the ration was as follows: 22% proteins, 42% 
carbohydrates, 4% fat, 10% mineral salts, 8% fibers, 1.4% 
calcium, 0.6% phosphorus, and 12% moisture. The ration was 
enriched with vitamins, mineral microelements and amino 
acids (lysine and methionine).
The GE of fluid and solid was determined in animals 
fasted for 24 hours (h) and receiving water ad libitum up to 
30 minutes (min) before the studies. 
In the study of the ICV effect of the drug, a stainless steel 
cannula (22G) was implanted into the right lateral ventricle 
of the brain 7 days before the experiment using previously 
established coordinates(12). 
Gastric emptying of liquid test meals  
(saline and 10% glucose)
The GE of the liquid meals was assessed in awake animals 
by the determination of percent gastric retention (GR) of 
2 mL/100 g animal weight of a saline or 10% glucose test 
meal labeled with phenol red at the concentration of 60 mg/
mL, 10 and 15 min, respectively, after administration by 
gavage using a standardized technique(9). Two modifications 
were introduced in the procedure originally described: 1. the 
reading for the determination of the concentration of the 
phenol red dye was performed with a spectrophotometer at 
560 nm wavelength, and 2. animal sedation for sacrifice was 
performed with halothane. 
Effect of baclofen administered ICV
An internal microinjection cannula (28G) connected 
to a 50 mL Hamilton syringe by polyethylene tubing was 
used for ICV injection. The animals were divided into three 
groups, respectively injected ICV with 10 µL vehicle (0) or 
an equal volume of a solution containing 1 or 2 mg baclofen, 
over a period of 30 seconds (s), with the system remaining 
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connected for an additional 30 s(12). The GE of the saline or 
10% glucose test meal was assessed 10 min after the removal 
of the internal cannula. 
Effect of IV baclofen 
The animals were divided into three groups respectively 
injected IV through a caudal vein with 1 mL/kg vehicle (0) 
or an equal volume of a solution containing 1 or 2 mg/kg 
baclofen. The GE of the saline or 10% glucose test meal was 
assessed 10 min later.
Gastric emptying of solid test meal
The method of Langhans et al.(24), with modifications 
made in our laboratory(36) and described in detail below, was 
used for the determination of solid GE in awake animals.
Solid ration was previously dried. Four days before the 
experiment the ration was weighed in a beaker of known 
weight, placed in an oven at 70o C and left there up to 10 
min before the beginning of the test. During this period the 
ration was weighed on at least four occasions until three stable 
weight measurements were obtained. The mean of these three 
weights minus the weight of the beaker was considered to 
be the dry weight.
For the test, the animal was transferred to a carefully 
washed and dried 30 cm long x 20 cm wide x 13 cm 
high individual propylene cage. After a 30 min period 
of  adaptation to this cage, the ration was offered to the 
animal for a period of  30 min. At the end of  this time, the 
animals received the ICV or IV injection and was returned 
to its individual cage, where it was left without receiving 
water or ration up to 90 s before the pre-established time 
(2 h starting from the beginning of  the offer of  ration) for 
the determination of  the GR of  the ingested solid food 
test meal. The animal was then transferred to a glass bell 
saturated with halothane as an anesthetic and left there 
for 30 s. The animal was then fixed to a flat surface and its 
abdomen was opened under inhalation anesthesia. After 
the stomach was visualized and the 2 pre-established hours 
had elapsed, the pylorus and the cardia were clamped and 
tied with cotton suture. The stomach was removed, washed 
on its outer surface, carefully dried with filter paper, and 
opened from the fundus to the great curvature. The gastric 
residue was transferred by washing the internal part of 
the stomach with distilled water to a previously weighed 
beaker marked with the number of  the animal. The beaker 
containing the gastric residue was then placed in an oven 
in order to obtain the dry weight.
The uneaten ration remaining in the plastic cage was 
carefully transferred with a brush to the original beaker, which 
was placed in an oven until the dry weight was obtained.
The amount of ration ingested was calculated by subtracting 
the dry weight of the uneaten ration from the dry weight 
of the offered ration. Gastric retention, as percentage, was 
determined from the amount of  ingested ration and the 
amount of solid gastric residue. The results are reported 
as % GR of the amount of ration ingested by each animal 
over a period of 30 min, 2 h after the beginning of ingestion.
The ingestion of ration, as mg/100 g animal weight, was 
calculated from the total amount ingested within 30 min (mg) 
divided by fasting animal weight (g) x 100.
Effect of ICV baclofen
The animals were divided into three groups respectively 
injected ICV with 10 mL of vehicle (0) or an equal volume 
of a solution containing 1 or 2 mg baclofen over a period of 
30 s, with the system remaining connected for an additional 
30 s. The drug was administered immediately after the end 
of the period of ration ingestion. This time of application 
was chosen to prevent a possible baclofen effect inhibiting 
the ingestion of ration, as observed in rats after IP injection 
of the drug(47).
Effect of IV baclofen
The animals were divided into three groups respectively 
injected IV through a caudal vein with 1 mL/kg vehicle (0) 
or an equal volume of a solution containing 1 or 2 mg/kg 
baclofen. The drug was administered immediately after the end 
of the period of ration ingestion. This time of application was 
chosen for the same reason as when the drug was injected ICV.
At the end of the experiments, all animals were sacrificed 
and those who had received the drug by ICV injection received 
10 mL 1% Evans blue solution by the same route. The brain 
was removed and fixed in 10% formalin for 24 h. After fixation, 
coronal brain sections were obtained and ICV injection was 
confirmed when the dye was visualized in the fourth ventricle.
The results of  % GR are reported as mean ± SEM. 
Data were analyzed statistically by ANOVA and pairs were 
compared by the Tukey test (∝ = 0.05). 
RESULTS
Gastric emptying of liquid test meals
Saline test meal. Effect of ICV and IV baclofen
ICV administration of baclofen, 2 mg/animal (Figure 1A), 
significantly reduced the GR of the saline test meal (mean 
± SEM= 18.1 ± 2.5%, n = 8) compared to control (33.2 ± 
2.2%, n = 8) indicating that administration of the drug in the 
CNS increased the GE of this type of meal. A nonsignificant 
reduction of GR was obtained with the baclofen dose of 
1 mg/animal (24.2 ± 3%, n = 8).
In contrast, IV administration of baclofen (1 and 2 mg/
kg) had no effect on the GR of this test meal (25.5 ± 1.9%, n 
= 8 and 29.1 ± 2.4%, n = 8, respectively) compared to control 
(31.8 ± 1.3%, n = 8) (Figure 1B).
Ten percent glucose meal. Effect of ICV and IV baclofen
ICV (Figure 2A) or IV (Figure 2B) administration of 
baclofen had no effect on the GE of a 10% glucose solution 
compared to control. In the group of animals receiving 2 mg 
baclofen ICV, GR (48.0 ± 2.2%, n = 8) was significantly lower 
compared to animals that received 1 mg by the same route 
(56 ± 2%, n = 8).
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It should be pointed out that the animals treated ICV 
ingested less ration, i.e., approximately 60% of the amount 
ingested by the animals treated IV.
Gastric emptying
ICV administration of 1 or 2 mg baclofen/animal (Figure 
3A) significantly increased the GR of the solid test meal 
(57.9 ± 6.5%, n = 6 and 66.6 ± 6.3%, n = 6, respectively) compared 
to control (35.1 ± 4.4%, n = 7), indicating that this drug, when 
administered in the CNS, delays the GE of this test meal.
IV administration of  2 mg/kg baclofen (Figure 3B) 
significantly increased the GR (71.9 ± 2.6%, n = 7) of the 




































FIGURE 1. Gastric retention (%) as mean ± SEM of a saline test meal, 
10 min after administration by gavage to rats. A) Seven days before the 
experiment, a metal tube was implanted into the right lateral ventricle 
of the brain of the animals. Through an internal cannula, the animals 
received ICV 10 µL of vehicle (0) or an equal amount of a solution 
containing 1 or 2 mg baclofen over a period of 30 s, with the system 
remaining connected for an equal period of time. Gastric retention was 
evaluated 10 min after removal of the internal cannula (n = 8). B) The 
animals received IV through a tail vein 1 mL/kg vehicle (0) or an equal 
amount of baclofen solution at the dose of 1 or 2 mg/kg and gastric 
retention was evaluated 10 min later (n = 8)
*= P<0.05 (Tukey test)
Solid test meal
Ingestion of ration
There was no significant difference in ration ingestion 
among the animals that received ICV baclofen at the doses 
of 0, 1 and 2 mg/animal, with respective mean ± SEM results 
of 580 ± 61 (n = 7), 642 ± 90 (n = 6) and 646 ± 136 (n = 6) 
mg/100 g animal weight.
Similarly, there was no significant difference in ration 
ingestion among the animals that received IV baclofen at 
the doses of 0, 1 and 2 mg/kg (n = 7), with respective mean 
± SEM results of 1,122 ± 112, 1,001 ± 124 and 948 ± 103 





































*= P<0.05 (Tukey test)
FIGURE 2. Gastric retention (%) as mean ± SEM of a 10% glucose 
test meal, 15 min after administration by gavage to rats. A) Seven days 
before the experiment, a metal tube was implanted into the right lateral 
ventricle of the brain of the animals. Through an internal cannula, the 
animals received ICV 10 µL of vehicle (0) or an equal amount of a solution 
containing 1 or 2 mg baclofen over a period of 30 s, with the system 
remaining connected for an equal period of time. Gastric retention was 
evaluated 10 min after removal of the internal cannula (n = 8). B) The 
animals received IV through a tail vein 1 mL/kg vehicle (0) or an equal 
amount of baclofen solution at the dose of 1 or 2 mg/kg and gastric 
retention was evaluated 10 min later (n = 8)
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It is interesting to note that ICV control animals had a 
lower GR than IV control animals.
DISCUSSION
The present results indicate that the racemic mixture of 
baclofen administered ICV (2 mg/animal) increased the GE 
of a non-caloric liquid saline test meal practically inert in its 
action on intestinal inhibitory receptors. The central effect of 
baclofen increasing GE would be expected due to its capacity 
of blocking in the DVC the mechanical inhibitory stimuli 







































FIGURE 3. Gastric retention (%) as mean ± SEM of the amounts of ration 
ingested (solid) by the animals over a period of 30 min, 2 hours after the 
beginning of ingestion. A) Seven days before the test, a metal tube was 
implanted into the right lateral ventricle of the brain of the animals. 
Immediately after the end of the time of ration ingestion, the animals 
received ICV through an internal cannula 10 µL of vehicle (0) or an equal 
amount of solution containing 1 or 2 mg baclofen over a period of 30 s, 
with the system remaining connected for an equal period of time.( ) = n. 
B) Immediately after the end of the time of ration ingestion, the animals 
received IV through a tail vein 1 mL/kg vehicle (0) or an equal amount of 
baclofen solution at the dose of 1 or 2 mg/kg (n = 7)
*= P<0.05 (Tukey test)
vagus nerve(1, 7, 8, 30, 31). As a consequence there is an increase 
in the tonus of the proximal stomach leading to a faster GE 
of a saline test meal. The effect on gastric tonus is produced 
by the levo(-)-enantiomer of baclofen(1).
Baclofen, a highly lipophilic compound, easily crosses 
the blood brain barrier(16). The ICV dose (~ 8 mg/kg), which 
significantly increased GE, was 250 times lower than the 
highest dose administered IV (2000 mg/kg). However, in the 
present study the same phenomenon was not observed with the 
IV doses, suggesting that an insufficient amount of the drug 
reached the DVC. Since baclofen also peripherally blocks the 
vagal afferent inhibitory stimuli triggered by the activation of 
tension receptors(4), we may conclude that IV administration 
did not cause a peripheral blockade of these stimuli.
ICV or IV injection of baclofen had no effect on the GE of 
a 10% glucose solution compared to control (Figure 2 A and 
B). The glucose solution is a caloric meal that, in contrast to 
saline, inhibits GE by stimulating intestinal receptors(33). These 
results agree with information that baclofen, in the CNS or 
peripherally, does not interfere with the response of activation 
of chemosensitive receptors in the small intestine, such as those 
activated by cholecystokinin (CCK), which participates in the 
feedback regulation of emptying(31). The data also agree with 
a study on healthy human adults which demonstrated that 
baclofen, during the postprandial period of a liquid caloric 
meal balanced with proteins, carbohydrates and fat, reduced 
the rate of transitory relaxation and increased the basal lower 
esophageal sphincter (LES) pressure compared to placebo. 
However, also compared to placebo, it did not change the 
reduced tonus and motility of the proximal stomach induced 
by the meal(25). The activation of chemosensitive CCK1 and/or 
5-HT3 receptors by the lipid, protein and carbohydrate content 
of the meal is responsible for the intestinal inhibition of GE 
and for the development of satiety(17, 20, 33, 34, 35, 37, 41). On this 
basis, these results in humans suggest that baclofen also does 
not interfere with the response of 5-HT3 receptor activation.
However, we cannot rule out the possibility that, with 
higher baclofen doses or a lower glucose concentration in 
the solution, the tonus of the proximal stomach was such 
as to overcome the inhibitory power of the caloric content 
of the meal, causing a faster GE.
In the present study, although the reason why animals 
treated ICV consumed less ration is unknown, this event 
may be related to the surgical procedure from implantation 
of  a tube in the lateral ventricle of  the brain. In the control 
ICV animals, GE was faster than in the IV controls although 
the animals ingested a smaller amount of  ration, a fact that 
may also have been related to the metabolic status of  the 
animals after the surgical procedure. Apparently these facts 
do not invalidate the analysis of  the effect of  baclofen on 
the GE of  solid food.
In view of this, it was observed that the administration of 
the drug ICV (1 and 2 mg/animal) and IV (2 mg/kg) delayed 
the GE of the solid meal (Figure 3 A and B). When baclofen 
was administered IV the delay of GE was observed only at the 
dose of 2 mg/kg, suggesting that higher IV doses of the drug 
are necessary to reach CNS levels able to produce this effect.
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Collares EF, Vinagre AM. Efeito do baclofen no esvaziamento gástrico de líquido e de sólido em ratos. Arq Gastroenterol. 2010;47(3)290-6.
RESUMO – Contexto - O ácido gama-aminobutírico (GABA) é um potente neurotransmissor inibitório. Há evidências que receptores GABAB localizados 
no complexo dorsal do vago e em fibras aferentes do nervo vago participam no controle da motricidade gastrointestinal. Objetivo - Avaliar o efeito 
intracerebroventricular (ICV) e intravenoso (IV) do baclofen, um agonista para receptores GABAB, sobre o esvaziamento gástrico de líquidos e de 
sólidos em ratos. Métodos - Foram utilizados ratos adultos Wistar, machos, de 250-300 g (n = 6-8 animais). O esvaziamento gástrico das refeições 
de prova líquidas, marcadas com fenol vermelho, foi avaliado através da determinação da % de retenção gástrica, 10 e 15 min após administração 
orogástrica das refeições salina e de glicose a 10%, respectivamente. As injeções ICV de baclofen (1 e 2 mg/animal) foram feitas através de uma sonda 
implantada no ventrículo lateral do cérebro e as injeções IV de baclofen (1 e 2 mg/kg) numa veia da cauda. O esvaziamento gástrico das refeições 
de prova líquidas foi determinado 10 ou 30 min após a administração de baclofen ICV ou IV, respectivamente. O esvaziamento gástrico da refeição 
sólida foi avaliado através da determinação da % de retenção gástrica 2 h após o início da ingestão da ração habitual do animal, ingerida durante 
30 min. As administrações de baclofen ICV (1 e 2 mg/animal) e IV (1 e 2 mg/kg) foram feitas imediatamente após o término da ingestão da refeição 
sólida. Os grupos controles receberam ICV ou IV veículo (solução salina estéril). Resultados - O grupo de animais que recebeu baclofen 2 mg/animal 
ICV apresentou retenção gástrica (média ± SEM) de salina (18.1 ± 2.5%) significantemente menor (P<0.05, teste de Tukey) em relação ao grupo 
controle (33.2 ± 2.2%). No grupo com administração IV da droga, a retenção gástrica da mesma refeição de prova não diferiu do seu controle. As 
administrações ICV e IV de baclofen não tiveram qualquer efeito no esvaziamento gástrico da solução de glicose a 10%, em relação aos seus controles. 
A administração ICV de 1 ou 2 mg/animal de baclofen aumentou significativamente as retenções gástricas da refeição de prova sólida (57.9 ± 6.5% 
e 66.6 ± 6.3%, respectivamente) em relação ao grupo controle (35.1 ± 4.4%). O mesmo fenômeno somente foi observado com a dose IV de 2 mg/kg 
(71.9 ± 2.6%) em relação ao grupo controle (52.7 ± 2.8%). Conclusões - O baclofen administrado: 1. ICV (2 mg/animal), mas não IV, aumentou o 
esvaziamento gástrico de uma refeição de prova líquida isotônica não-calórica (salina); 2. ICV ou IV, não teve efeito sobre o esvaziamento da solução 
de glicose a 10%; 3) ICV (1 e 2 mg/animal) e IV (2 mg/kg) retardou o esvaziamento gástrico da refeição sólida.
DESCRITORES – Esvaziamento gástrico. Baclofeno. Ratos.
Since baclofen increases the amplitude and frequency 
of gastric contractions(1) an increased GE of the solid meal 
would be expected, a fact that did not occur. Although the 
reason for this is unknown, two hypotheses may be raised 
to explain the phenomenon. The first is based on the fact 
that baclofen has been proposed as an effective drug for the 
treatment of gastroesophageal reflux disease (GERD) by its 
ability to inhibit the intermittent relaxation of the LES. This 
is the main physiopathological mechanism that determines 
this dysfunction, thus reducing, with the therapeutic use of 
baclofen, the reflux of stomach content to the esophagus in 
humans(11, 22, 23, 26, 48). There is no information about the effect 
of baclofen on the pylorus. However, we may speculate that, 
if  this drug interferes with the intermittent motor activity of 
this region, as described for the LES, the increased frequency 
or duration of pylorus contractions may compromise the GE 
of solids. A second hypothesis could be that the increased 
duodenal contractions induced by baclofen(16), in opposition to 
its effect on the increase of gastric contraction(1), would impair 
the GE of a solid meal such as that used in the present study. 
These hypotheses should be tested by means of experiments 
specifically planned for this purpose.
Our results differ substantially from those reported in 
the single experimental study conducted to assess the effect 
of baclofen on GE, which suggested that the drug delays 
liquid GE and accelerates solid GE. The methodology used 
in the cited study(40) differed from ours in several aspects, 
as follows: 1) the animals used were mice; 2) baclofen was 
administered IP in a large volume of vehicle (10 mL/kg); 3) 
GE was evaluated by an indirect method by determining 
13CO2 in expired air, using 13C]octanoic acid as a marker of 
the liquid and solid meals; 4) the caloric liquid meal used 
consisted of lipid; 5) the solid meal consisted of cooked 
egg yolk, which is easily fragmented; 6) in the evaluation of 
solid GE, baclofen was administered before the beginning 
of ingestion and it was not clear how much time the animals 
spent in the ingestion of this meal. Thus, it is impossible to 
compare the studies although in our case the results may be 
interpreted, in large part, according to the reported effects 
of baclofen on gastric motility.
The effect of  baclofen on the GE of cow’s milk was 
evaluated in a study on children with GERD(29), but not in 
controls, and the authors concluded that the drug, in contrast 
to placebo, accelerated GE. However, many of the patients 
included in the study presented abnormal gastric motility 
which was “normalized” by baclofen. Thus, this effect may 
possibly have “improved” GE in these children with GERD. 
On the basis of this and of the above results, it is possible 
that baclofen at therapeutic doses does not alter the GE of 
a caloric liquid meal in control subjects.
In conclusion, in the present study baclofen administered 
1. ICV (2 mg/animal), but not IV (1 and 2 mg/kg) increased the 
GE of a non-caloric isotonic liquid test meal (saline); 2. when 
administered ICV or IV, it had no effect on the GE of a 10% 
glucose solution; and 3. when administered ICV (1 and 2 mg/
animal) and IV (2 mg/kg) it delayed the GE of a solid meal.
Collares EF, Vinagre AM.  Effect of baclofen on liquid and solid gastric emptying in rats
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